Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,068
datasets available to search
ShareScore release 0.9.0
Dataset results
1,068 results for “PD-1”
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
ClinicalTrials.gov study NCT06190782. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT07159217. IPD Sharing: NO. Countries: 1. Publications: 1.
Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy
ClinicalTrials.gov study NCT05276284. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
ClinicalTrials.gov study NCT05659186. IPD Sharing: Not stated. Countries: 1. Publications: 15.
The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients
ClinicalTrials.gov study NCT06357806. IPD Sharing: NO. Countries: 1. Publications: 1.
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05334329. IPD Sharing: Not stated. Countries: 1. Publications: 2.
PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor
ClinicalTrials.gov study NCT03615313. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC
ClinicalTrials.gov study NCT05332496. IPD Sharing: NO. Countries: 1. Publications: 4.
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
ClinicalTrials.gov study NCT04812002. IPD Sharing: NO. Countries: 1. Publications: 8.
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC
ClinicalTrials.gov study NCT05332821. IPD Sharing: NO. Countries: 1. Publications: 5.
A Trial of Sintilimab Plus Anlotinib For Metastatic NSCLC After First-Line PD-1 Inhibitor
ClinicalTrials.gov study NCT04691388. IPD Sharing: NO. Countries: 1. Publications: 1.
Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
ClinicalTrials.gov study NCT06992024. IPD Sharing: Not stated. Countries: 1. Publications: 5.
PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT02867345. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.
ClinicalTrials.gov study NCT03755440. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma
ClinicalTrials.gov study NCT04728568. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03958097. IPD Sharing: NO. Countries: 1. Publications: 2.
Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer.
ClinicalTrials.gov study NCT04368273. IPD Sharing: Not stated. Countries: 1. Publications: 1.
DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04229355. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT04418154. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer
ClinicalTrials.gov study NCT04836728. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.